Avance, Basel GmbHAvance is a Swiss company specialized in valuation in life sciences. The company serves pharma, biotech and investors with valuation tools, publications and services related to valuation and financial aspects of licensing, fundraising, investing and portfolio managment. |
 |
List of reports from Avance, Basel GmbH
|
Biotech Success Rates - Period 2002 - 2009
4/23/2009 | published by: Avance, Basel GmbH
... publicly traded biotech companies with more than 1,500 drugs in development fort he period 2002 - 2009. The success rates are discussed per disease group and put into context to existing data on drug development ...
|
more...
|
$1,285.00
|
